Editorial Staff

Drug Rebates: How Pharmacy Benefit Managers Manipulate Price & Limit Choice

/0 Comments/in , , , , , /by Editorial Staff
Share on Facebook
Share on Twitter
Share on
LinkedIn
+

Join host Joe Selvaggi and his guest Dr. Bill Smith as they discuss the complex incentive structure between drug manufacturers, health plans, and pharmacy benefit managers. In this episode, they focus on how drug rebates work and how a system intended to optimize value may actually deliver higher costs and fewer choices. Joe and Bill also use this framework to speculate on the price of a COVID-19 vaccine, and who will likely pay for it.

Guest:

Dr. William Smith is Visiting Fellow in Life Sciences at Pioneer Institute. Bill has recently published a working paper entitled, Growing Drug Rebates Hurt Both Consumers and our Healthcare System.  He is here to share with us his findings on how drug rebates work and how they affect which drugs we are prescribed and how much we pay. Bill has spent ten years at Pfizer as Vice President of Public Affairs and Policy, has been President of a medical device company,  and has had senior staff positions with U.S. Congressional House leadership, the White House, and in the Governor’s office in Massachusetts. He earned his PhD at the Catholic University of America and a bachelor’s degree from Georgetown University.

Get new episodes of Hubwonk in your inbox!

Related Content

Farmers Welfare Bill: Rethinking Costly and Environmentally Distortive Subsidies

Joe Selvaggi discusses the cost and consequences of the $1.5 trillion decade-long subsidies in the farm bill with Chris Edwards, Chair of Fiscal Studies at the Cato Institute. These subsidies have the potential to negatively impact incentives for consumers, producers, and those concerned about the environment.

Predatory Tax Ruling: Supreme Court Closes Door on Home Equity Theft

Joe Selvaggi talks with Pacific Legal Foundation’s state legal policy deputy, attorney Jim Manley, about home equity theft, a practice that has taken 350 properties in Massachusetts, dispossessing homeowners of more than $50 million in equity.

Sweden’s Pandemic Paradigm: Does Trust in Citizenry Save Lives

Joe Selvaggi talks with Johan Norberg, author and senior fellow at CATO Institute, about his analysis of Sweden’s resistance to government-mandated COVID-19 control measures, as well as Sweden’s public health outcomes relative to the U.S and peer nations.

Breast Cancer Risk: Testing to Tailored Screening, Treatment, and Prevention

Joe Selvaggi talks with precision medicine expert, Alva 10 CEO Hannah Mamuszka about how individualized testing can both detect and substantially reduce the incidence of breast cancer, a disease that accounts for more than 40k deaths each year.

Landlord’s Foreseeable Duty: Who Is Liable When Crime Lands on the Doorstep?

Joe Selvaggi talks with retired Federal Judge Frank Bailey, president of Pioneer Public Interest Law Center, about the Massachusetts Supreme Judicial Court's decision in Hill-Junious v. UTP Realty, LLC, regarding the limits of liability for a landlord when a murder occurs near her tenant’s location, and the challenges facing small entrepreneurs in high-crime communities.

Trump’s Trial’s Tribulations: Legal Merits of Four Federal Felony Fraud Indictments

Joe Selvaggi talks with legal scholar and George Mason University professor Ilya Somin about the legal merits of the federal indictments against former President Donald Trump and what is likely to come next in the legal proceedings against him and other defendants in the cases involving the aftermath of the 2020 presidential election.

Black Box Budget: Late, Loaded, and Lacking Transparency

Joe Selvaggi talks with Pioneer Institute’s Senior Fellow in Economic Opportunity Eileen McAnneny about the features and flaws of the recently passed 2024 Massachusetts state budget now waiting for Governor Healey’s approval.

Sabotaging Strategic Success: How Price Controls Could Imperil U.S. Pharma Industry

Joe Selvaggi talks with Pioneer Institute’s Director of Life Sciences Initiative Dr. Bill Smith about the policies that drove biopharmaceutical company from Europe to the U.S., and how proposed, similar price controls in President Biden’s Fair Prices Act could distort incentives away from innovation and threaten the success of a thriving and vital U.S. industry.

Local Elections Matter: City Governance Driven by Those Who Show Up

Joe Selvaggi talks with Suffolk County Assistant District Attorney and candidate for Boston City Council’s 8th District Montez Haywood about the city council’s role in local governance and the salient issues at stake in the July 25 special election.

Diagnosing Debilitating Debt: Are We Undertaxing or Overspending?

Joe Selvaggi talks with Cato Institute’s Director of Tax Policies, Dr. Adam Michell about the sources of recent record levels of deficits and debt to understand a policy path toward fiscal sustainability that is politically viable.

Court Compels Colorblindness: Harvard Told No Exceptions for Equality Under Law

Joe Selvaggi speaks with Thomas A. Berry of Cato Institute about the Supreme Court’s ruling in Students for Fair Admissions Inc. v. President & Fellows of Harvard College, its impact on affirmative action, and what comes next for colleges seeking to ensure diverse enrollments.

Baking Young Minds: Scientific Concerns for Cannabis on Kids

Joe Selvaggi talks with professor of psychiatry Dr. Ryan Sultan about the findings of his recently released study on the effects of cannabis on the mental health of American adolescents. Dr. Sultan’s work shows a substantial correlation between cannabis use and negative mental health outcomes.

Curing Medicaid’s Cold: Unwinding Pandemic Expansion Before Federal Funds End

Joe Selvaggi talks with healthcare policy expert Dr. Brian Blase about Medicaid expansion during the COVID-19 healthcare emergency and how states can efficiently reexamine eligibility criteria so as to protect the vulnerable before federal support expires.

Climate Change Reset: Catastrophic Consensus Cools As New Models Emerge

Joe Selvaggi talks with climate expert Dr. Judith Curry about the insights contained in her newly released book, Climate Uncertainty and Risk: Rethinking our Response, in which she tracks the evolution of climate science from model development, to political weapon, to an emerging view that the best response to a changing climate is to build resiliency.